Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jordi Serra & Noemi Caballero. (2016) Dexloxiglumide for the treatment of constipation predominant irritable bowel syndrome. Expert Opinion on Pharmacotherapy 17:14, pages 1969-1974.
Read now
Read now
Sarah J. Roffey, R. Scott Obach, Jenny I. Gedge & Dennis A. Smith. (2007) What is the Objective of the Mass Balance Study? A Retrospective Analysis of Data in Animal and Human Excretion Studies Employing Radiolabeled Drugs. Drug Metabolism Reviews 39:1, pages 17-43.
Read now
Read now
Articles from other publishers (11)
David A. Tess, Heather Eng, Amit S. Kalgutkar, John Litchfield, David J. Edmonds, David A. Griffith & Manthena V. S. Varma. (2020) Predicting the Human Hepatic Clearance of Acidic and Zwitterionic Drugs. Journal of Medicinal Chemistry 63:20, pages 11831-11844.
Crossref
Crossref
Yu Gao, Jingwei Shao, Zhou Jiang, Jianzhong Chen, Songen Gu, Suhong Yu, Ke Zheng & Lee Jia. (2014) Drug enterohepatic circulation and disposition: constituents of systems pharmacokinetics. Drug Discovery Today 19:3, pages 326-340.
Crossref
Crossref
R. P. Manger. (2010) A generic biokinetic model for Carbon-14. Radiation Protection Dosimetry 143:1, pages 42-51.
Crossref
Crossref
Magda F. Morton, Terrance D. Barrett, Wen Yan, Jamie M. Freedman, Guy Lagaud, Clodagh E. Prendergast, Veronica Moreno, Jayashree Pyati, Katherine Figueroa, Lina Li, Xiaodong Wu, Michele Rizzolio, James G. Breitenbucher, Kelly McClure & Nigel P. Shankley. (2007)
3-[5-(3,4-Dichloro-phenyl)-1-(4-methoxy-phenyl)-1
H
-pyrazol-3-yl]-2-
m
-tolyl-propionate (JNJ-17156516), a Novel, Potent, and Selective Cholecystokinin 1 Receptor Antagonist: In Vitro and in Vivo Pharmacological Comparison with Dexloxiglumide
. Journal of Pharmacology and Experimental Therapeutics 323:2, pages 562-569.
Crossref
Crossref
Stefano Persiani, Massimo D???Amato, Abhijeet Jakate, Partha Roy, Julie Wangsa, Ram Kapil & Lucio C Rovati. (2006) Pharmacokinetic Profile of Dexloxiglumide. Clinical Pharmacokinetics 45:12, pages 1177-1188.
Crossref
Crossref
Abhijeet S. Jakate, Partha Roy, Alpita Patel, Wattanaporn Abramowitz, Stefano Persiani, Julie Wangsa & Ram Kapil. (2005) Effect of azole antifungals ketoconazole and fluconazole on the pharmacokinetics of dexloxiglumide. British Journal of Clinical Pharmacology 60:5, pages 498-507.
Crossref
Crossref
Partha Roy, Abhijeet S. Jakate, Alpita Patel, Wattanaporn Abramowitz, Julie Wangsa, Stefano Persiani & Ram Kapil. (2005) Effect of Multiple-Dose Dexloxiglumide on the Pharmacokinetics of Oral Contraceptives in Healthy Women. The Journal of Clinical Pharmacology 45:3, pages 329-336.
Crossref
Crossref
Michael Hall, Stefano Persiani, Yen‐Ling Cheung, Anne Matthews, Z. Richard Cybulski, Jeremy D. Holding, Ram Kapil, Massimo D'Amato, Francesco Makovec & Lucio C. Rovati. (2004) Interaction of dexloxiglumide, a cholecystokinin type‐1 receptor antagonist, with human cytochromes P450. Biopharmaceutics & Drug Disposition 25:4, pages 163-176.
Crossref
Crossref
C. Webber, C. A. Stokes, S. Persiani, F. Makovec, A. McBurney, R. P. Kapil, B. A. John, M. D’Amato & L. F. Chasseaud. (2004) Absorption, distribution, metabolism and excretion of the cholecystokinin-1 antagonist dexloxiglumide in the dog. European Journal of Drug Metabolism and Pharmacokinetics 29:1, pages 15-23.
Crossref
Crossref
Sanna Tolle‐Sander, Andreas Grill, Hemant Joshi, Ram Kapil, Stefano Persiani & James E. Polli. (2003) Characterization of Dexloxiglumide in vitro Biopharmaceutical Properties and Active Transport. Journal of Pharmaceutical Sciences 92:10, pages 1968-1980.
Crossref
Crossref
C. Webber, C. A. Stokes, S. Persiani, F. Makovec, A. McBurney, R. P. Kapil, B. A. John, T. L. Houchen, M. D’Amato & L. F. Chasseaud. (2003) Absorption, distribution, metabolism and excretion of the cholecystokinin-1 antagonist dexloxiglumide in the rat. European Journal of Drug Metabolism and Pharmacokinetics 28:3, pages 201-212.
Crossref
Crossref